A prospective, open label, single arm study to evaluation the safety and efficacy of an olmesartan medoxomil based treatment regimen in elderly patients with hypertension.
Phase of Trial: Phase IV
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Olmesartan medoxomil/hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms BeniSILVER
- Sponsors Daiichi Sankyo Inc
- 15 Sep 2009 Actual patient number (178) added as reported by ClinicalTrials.gov.
- 15 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 May 2009 Results data available and presented at ASH 2009, as reported in a media release from Daiichi Sankyo Inc.